CQENS Technologies Inc. has filed an 8-K report indicating that it has approved an amendment to the terms of certain common stock purchase warrants held by Xten Capital Group, Inc. The amendment, dated September 3, 2026, modifies the exercise periods for the Series A and Series B warrants issued as part of a 2020 asset purchase agreement.
Originally, the Series A Warrant was exercisable for 7,000,000 shares of common stock at an exercise price of $5.31 per share, with an exercise period commencing on September 30, 2023, and expiring on September 30, 2026. The Series B Warrant was also exercisable for 7,000,000 shares at the same price, with an exercise period commencing on September 30, 2026, and expiring on September 30, 2029.
Under the terms of the amendment, Xten Capital Group agreed to delay the exercise period of the Series B Warrant. Consequently, the Series B Warrant will now commence on September 30, 2029, and expire on September 30, 2032. In exchange for this delay, the Company amended the exercise period of the Series A Warrant. The Series A Warrant will now commence on September 30, 2029, and expire on September 30, 2032.
The Company notes that all other terms of the warrants remain unchanged and in full force and effect. The filing includes an exhibit containing the full text of the amendment.
